Annual EBIT
-$68.86 M
-$17.66 M-34.50%
December 31, 2023
Summary
- As of February 8, 2025, JSPR annual earnings before interest & taxes is -$68.86 million, with the most recent change of -$17.66 million (-34.50%) on December 31, 2023.
- During the last 3 years, JSPR annual EBIT has fallen by -$48.18 million (-232.94%).
- JSPR annual EBIT is now -232.94% below its all-time high of -$20.68 million, reached on December 31, 2020.
Performance
JSPR EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$19.89 M
-$3.90 M-24.36%
September 30, 2024
Summary
- As of February 8, 2025, JSPR quarterly earnings before interest & taxes is -$19.89 million, with the most recent change of -$3.90 million (-24.36%) on September 30, 2024.
- Over the past year, JSPR quarterly EBIT has dropped by -$527.00 thousand (-2.72%).
- JSPR quarterly EBIT is now -2295.25% below its all-time high of $906.00 thousand, reached on December 31, 2020.
Performance
JSPR Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$68.68 M
-$527.00 K-0.77%
September 30, 2024
Summary
- As of February 8, 2025, JSPR TTM earnings before interest & taxes is -$68.68 million, with the most recent change of -$527.00 thousand (-0.77%) on September 30, 2024.
- Over the past year, JSPR TTM EBIT has dropped by -$3.80 million (-5.85%).
- JSPR TTM EBIT is now -600.23% below its all-time high of -$9.81 million, reached on December 31, 2020.
Performance
JSPR TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
JSPR EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.5% | -2.7% | -5.8% |
| 3 y3 years | -232.9% | -2.7% | -5.8% |
| 5 y5 years | -232.9% | -2.7% | -5.8% |
JSPR EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -87.0% | at low | -66.3% | at low | -106.0% | +1.9% |
| 5 y | 5-year | -232.9% | at low | -2295.3% | at low | -600.2% | +1.9% |
| alltime | all time | -232.9% | at low | -2295.3% | at low | -600.2% | +1.9% |
Jasper Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$19.89 M(+24.4%) | -$68.68 M(+0.8%) |
| Jun 2024 | - | -$15.99 M(+6.1%) | -$68.15 M(-2.6%) |
| Mar 2024 | - | -$15.07 M(-15.0%) | -$69.99 M(+1.6%) |
| Dec 2023 | -$68.86 M(+34.5%) | -$17.73 M(-8.5%) | -$68.86 M(+6.1%) |
| Sep 2023 | - | -$19.36 M(+8.6%) | -$64.88 M(+11.4%) |
| Jun 2023 | - | -$17.83 M(+27.8%) | -$58.23 M(+11.2%) |
| Mar 2023 | - | -$13.95 M(+1.5%) | -$52.37 M(+2.3%) |
| Dec 2022 | -$51.20 M | -$13.75 M(+8.2%) | -$51.20 M(-2.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$12.71 M(+6.2%) | -$52.71 M(+21.4%) |
| Jun 2022 | - | -$11.96 M(-6.4%) | -$43.40 M(+8.9%) |
| Mar 2022 | - | -$12.78 M(-16.2%) | -$39.86 M(+19.6%) |
| Dec 2021 | -$36.83 M(+78.1%) | -$15.26 M(+348.3%) | -$33.33 M(+94.1%) |
| Sep 2021 | - | -$3.40 M(-59.6%) | -$17.17 M(-29.9%) |
| Jun 2021 | - | -$8.42 M(+34.6%) | -$24.48 M(+52.4%) |
| Mar 2021 | - | -$6.25 M(-790.3%) | -$16.06 M(+63.8%) |
| Dec 2020 | -$20.68 M | $906.00 K(-108.5%) | -$9.81 M(-8.5%) |
| Sep 2020 | - | -$10.71 M | -$10.71 M |
FAQ
- What is Jasper Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Jasper Therapeutics?
- What is Jasper Therapeutics annual EBIT year-on-year change?
- What is Jasper Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly EBIT year-on-year change?
- What is Jasper Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Jasper Therapeutics?
- What is Jasper Therapeutics TTM EBIT year-on-year change?
What is Jasper Therapeutics annual earnings before interest & taxes?
The current annual EBIT of JSPR is -$68.86 M
What is the all time high annual EBIT for Jasper Therapeutics?
Jasper Therapeutics all-time high annual earnings before interest & taxes is -$20.68 M
What is Jasper Therapeutics annual EBIT year-on-year change?
Over the past year, JSPR annual earnings before interest & taxes has changed by -$17.66 M (-34.50%)
What is Jasper Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of JSPR is -$19.89 M
What is the all time high quarterly EBIT for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly earnings before interest & taxes is $906.00 K
What is Jasper Therapeutics quarterly EBIT year-on-year change?
Over the past year, JSPR quarterly earnings before interest & taxes has changed by -$527.00 K (-2.72%)
What is Jasper Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of JSPR is -$68.68 M
What is the all time high TTM EBIT for Jasper Therapeutics?
Jasper Therapeutics all-time high TTM earnings before interest & taxes is -$9.81 M
What is Jasper Therapeutics TTM EBIT year-on-year change?
Over the past year, JSPR TTM earnings before interest & taxes has changed by -$3.80 M (-5.85%)